NCT00002936View on ClinicalTrials.gov

Altretamine and Etoposide in Treating Patients With HIV-Related Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 1996

Primary Completion Date

January 31, 2007

Conditions
LymphomaSarcoma
Interventions
DRUG

altretamine

DRUG

etoposide

Trial Locations (1)

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Roswell Park Cancer Institute

OTHER

NCT00002936 - Altretamine and Etoposide in Treating Patients With HIV-Related Cancer | Biotech Hunter | Biotech Hunter